A growing body of evidence has suggested EBV is a major environmental risk factor for MS. Learn more about its association with the disease.| Multiple Sclerosis News Today
MS is categorized into four main types: CIS, RRMS, SPMS, and PPMS. Learn more about each different type, their presentation, and treatment.| Multiple Sclerosis News Today
Rituximab is commonly used off-label in multiple sclerosis patients. Learn more about its uses, side effects, and clinical testing.| Multiple Sclerosis News Today
Symptoms and early signs of MS vary from person to person. Common symptoms include movement problems, pain, fatigue, and vision problems.| Multiple Sclerosis News Today
MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.| Multiple Sclerosis News Today
Many MS patients experience primary headaches, and disease-modifying therapies may play different roles in their development, per a study.| Multiple Sclerosis News Today